Showing results (291-300 of 321) with videos related to
Sort By:
Pageof 33
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 4, 2004
Intraoperative innominate and common carotid intervention combined with carotid endarterectomy: a "true" endovascular surgical approachDavid E Allie, Chris J Hebert, Mitchell D Lirtzman, et al.Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 10, 2004
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experienceDavid E Allie, Chris J Hebert, Mitchell D Lirtzman, et al.Arthritis and Rheumatism|January 11, 2005
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory diseaseTammy M Martin, Ge Zhang, Jingchun Luo, et al.Molecular Cancer Therapeutics|June 10, 2024
TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to RadiotherapyTriet Nguyen, Francesca A Carrieri, Nick Connis, et al.Journal of Pediatric Gastroenterology and Nutrition|December 28, 2017
Management of Acute Pancreatitis in the Pediatric Population: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Pancreas CommitteeMaisam Abu-El-Haija, Soma Kumar, Jose Antonio Quiros, et al.The Journal of Experimental Medicine|April 1, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune responseMiho Tanaka, Lotus Lum, Kenneth H Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung CancerNoura J Choudhury, W Victoria Lai, Alex Makhnin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancerMatthew G Fury, Eric Sherman, Donna Lisa, et al.International Journal of Molecular Sciences|April 13, 2023
Identification of a Small Molecule Compound Active against Antibiotic-Tolerant Staphylococcus aureus by Boosting ATP SynthesisHo-Ting-Venice Iu, Pak-Ming Fong, Hin-Cheung-Bill Yam, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2004
Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: the power-pulse spray techniqueDavid E Allie, Chris J Hebert, Mitchell D Lirtzman, et al.Pageof 33